Profiles, diagnostic process, and patterns of care of patients with stage III non-small cell lung cancer: A French national study.
Fiche publication
Date publication
janvier 2024
Journal
Respiratory medicine and research
Auteurs
Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel, Dr MARTIN Etienne
Tous les auteurs :
Auliac JB, Greillier L, Martin E, Falcoz PE, Boisselier P, Ano S, Lefrançois M, Cortot A
Lien Pubmed
Résumé
The management of stage III non-small-cell lung cancer (NSCLC) remains heterogeneous and complex, even after the approval of immune checkpoint inhibitors post-chemoradiotherapy (CRT). This observational study from France evaluated real-world practices in managing stage III NSCLC.
Mots clés
Chemoradiotherapy, Immunotherapy, NSCLC, Stage III, Surgery
Référence
Respir Med Res. 2024 01 23;85:101087